Key Dates

Related Announcements

RFA-CA-21-055 - Translational and Basic Science Research in Early Lesions: Coordinating and Data Management Center (U24 Clinical Trial Not Allowed)

Issued by

National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to correct the Plans for the Required Areas of Responsibility subsection of the Research Strategy in Funding Opportunity Announcement (FOA) RFA-CA-21-055, “Translational and Basic Science Research in Early Lesions: Coordinating and Data Management Center (U24 Clinical Trial Not Allowed)".

The following section of RFA-CA-21-055 has been modified:

Currently Reads:

Section IV. Application and Submission Information, 2. Content and Form of Application Submission

PHS 398 Research Plan

Research Strategy

Section 2. Plans for the Required Areas of Responsibility

Applicants must describe in detail the development, implementation, and maintenance plans for each required area of responsibility (defined in Section I. Research Objectives of this FOA). These main areas of responsibility include:

(a) Consortium Coordination:

• • Provide logistical and administrative assistance in arranging meetings of the Steering Committee (e.g. preparing, distributing, and maintaining minutes of meetings), including the selection and contract development with appropriate venues as decided by the Steering committee. There will be one face-to-face Steering Committee Meeting per year and monthly teleconferences;

Modified to read (change shown in bold italics):

Section IV. Application and Submission Information, 2. Content and Form of Application Submission

PHS 398 Research Plan

Research Strategy

Section 2. Plans for the Required Areas of Responsibility

Applicants must describe in detail the development, implementation, and maintenance plans for each required area of responsibility (defined in Section I. Research Objectives of this FOA). These main areas of responsibility include:

(a) Consortium Coordination:

• • Provide logistical and administrative assistance in arranging meetings of the Steering Committee (e.g. preparing, distributing, and maintaining minutes of meetings), including the selection and contract development with appropriate venues as decided by the Steering committee. There will be two face-to-face Steering Committee Meetings per year and monthly teleconferences;

All other aspects of the FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Scientific Research Contact(s)

Christos Patriotis, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-7134
Email: patriotisc@mail.nih.gov

Financial/Grants Management Contact(s)

Amy Bartosch
National Cancer Institute (NCI)
Telephone: 240-276-6912
Email: bartoschar@mail.nih.gov